Aflac Inc AFL
We take great care to ensure that the data presented and summarized in this overview for AFLAC INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AFL
View all-
Japan Post Holdings Co., Ltd.52.3MShares$5.47 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA51.3MShares$5.37 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY40.1MShares$4.19 Billion0.08% of portfolio
-
State Street Corp Boston, MA25MShares$2.61 Billion0.1% of portfolio
-
Wells Fargo & Company San Francisco, CA15.3MShares$1.6 Billion0.37% of portfolio
-
Geode Capital Management, LLC Boston, MA12.5MShares$1.3 Billion0.1% of portfolio
-
Morgan Stanley New York, NY8.56MShares$895 Million0.06% of portfolio
-
Northern Trust Corp Chicago, IL7.3MShares$763 Million0.11% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL5.25MShares$549 Million0.13% of portfolio
-
First Trust Advisors LP Wheaton, IL4.46MShares$466 Million0.43% of portfolio
Latest Institutional Activity in AFL
Top Purchases
Top Sells
About AFL
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Insider Transactions at AFL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Max Broden Sr. EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Indirect |
12
-3.16%
|
$1,236
$103.34 P/Share
|
|
Feb 13
2025
|
Daniel P Amos Chairman of the Board, CEO |
SELL
Bona fide gift
|
Direct |
89,800
-10.79%
|
-
|
|
Feb 11
2025
|
Max Broden Sr. EVP, CFO |
BUY
Grant, award, or other acquisition
|
Indirect |
78
+17.03%
|
-
|
|
Feb 11
2025
|
Daniel P Amos Chairman of the Board, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
130,511
-13.56%
|
$13,312,122
$102.61 P/Share
|
|
Feb 11
2025
|
Daniel P Amos Chairman of the Board, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
294,981
+23.45%
|
-
|
|
Feb 11
2025
|
Audrey B Tillman Sr. Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
26,733
-9.36%
|
$2,726,766
$102.61 P/Share
|
|
Feb 11
2025
|
Audrey B Tillman Sr. Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
62,938
+18.06%
|
-
|
|
Feb 11
2025
|
Virgil Raynard Miller President, Aflac Inc. and U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,276
-14.14%
|
$436,152
$102.61 P/Share
|
|
Feb 11
2025
|
Virgil Raynard Miller President, Aflac Inc. and U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
12,742
+29.64%
|
-
|
|
Feb 11
2025
|
Charles D Lake Ii Chairman & Rep. Director, ALIJ |
BUY
Grant, award, or other acquisition
|
Direct |
41,412
+28.69%
|
-
|
|
Feb 11
2025
|
Masatoshi Koide Pres. and Rep. Director, ALIJ |
BUY
Grant, award, or other acquisition
|
Direct |
43,805
+25.22%
|
-
|
|
Feb 11
2025
|
Bradley Eugene Dyslin Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,589
-22.27%
|
$570,078
$102.61 P/Share
|
|
Feb 11
2025
|
Bradley Eugene Dyslin Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
13,729
+35.36%
|
-
|
|
Feb 11
2025
|
Max Broden Sr. EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,535
-14.75%
|
$2,298,570
$102.61 P/Share
|
|
Feb 11
2025
|
Max Broden Sr. EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
53,583
+25.97%
|
-
|
|
Feb 11
2025
|
Steven Kent Beaver EVP, CFO Aflac Japan |
SELL
Payment of exercise price or tax liability
|
Direct |
4,103
-8.58%
|
$418,506
$102.61 P/Share
|
|
Feb 11
2025
|
Steven Kent Beaver EVP, CFO Aflac Japan |
BUY
Grant, award, or other acquisition
|
Direct |
12,301
+20.45%
|
-
|
|
Feb 10
2025
|
Robin Littrell Blackmon SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
230
-3.21%
|
$23,460
$102.61 P/Share
|
|
Feb 10
2025
|
Frederic Jean Guy Simard EVP, COO & CFO, Aflac U.S. |
BUY
Discretionary transaction
|
Indirect |
201
+25.77%
|
$20,703
$103.58 P/Share
|
|
Feb 07
2025
|
Robin Littrell Blackmon SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
285
-3.82%
|
$29,355
$103.58 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 567K shares |
|---|---|
| Exercise of conversion of derivative security | 47.1K shares |
| Bona fide gift | 386 shares |
| Discretionary transaction | 201 shares |
| Open market or private sale | 66.9K shares |
|---|---|
| Payment of exercise price or tax liability | 212K shares |
| Bona fide gift | 335K shares |